Print this article
- 02/11/2016

MITOKINYL®
The interactive solution to harmful urban pollution

HPC Today

To combat pollution, a true enemy of the skin, SILAB is offering MITOKINYL®, an anti-pollution natural active ingredient rich in glucomannans and able to combat harmful environmental stress via a unique regulation pathway.

SILAB Research is the first laboratory to identify the central role of mitokines in an optimum antipollution strategy. Thanks to a sophisticated intracellular communication mechanism, these mediators, released by mitochondria under the effects of pollution, connect the skin to its environment and initiate an appropriate anti-stress response.

During a pollution attack, MITOKINYL® : • regulates the two major biological pathways of pollutant stress response: the synthesis of mitokines (prohibitines) is normalized and the aryl-hydrocarbon receptor is deactivated; • forms an effective, stratified, functional barrier; • optimizes complexion tone and radiance in Caucasian and Asian volunteers. MITOKINYL® protects fragile skin against urban stresses and is recommended in all antipollution facial and body skincare products.

MITOKINYL® restores the mitokines pathway Study in vitro on SILABSKIN® RE reconstructed epidermis.

Modeling in vitro has shown that stresses resulting from pollution cause a significant reduction in the synthesis of mitokines (prohibitins) by human keratinocytes. This reduction is due to the direct effect of pollutants (benzo[a]pyrene: -1 When subjected to an environment mimicking the consequences of pollution, the synthesis of prohibitin by SILABSKIN® RE is significantly reduced by 2

MITOKINYL® favors the construction of a stratified and functional epidermis Study in vitro on SILABSKIN® RE reconstructed epidermis.

When faced with a pollution incident, the epidermal construction and the synthesis of epidermal differentiation markers, cytokeratin 10, filaggrin and loricrin, are significantly reduced. Tested at 0.2

MITOKINYL® revitalizes the recuperation capacity of the skin barrier Tewameter study in vivo.

MITOKINYL® improves the recuperation capacity of the barrier function of the skin. In only 4 days, MITOKINYL® restores the barrier effect to more than 9

MITOKINYL® inhibits melanogenesis Study in vitro on cultures of melanocytes.

Tested at

MITOKINYL® improves skin complexion – Complexion radiance and the Caucasian panel Study in vivo on Caucasian volunteers.

After 14 days of twice daily applications, MITOKINYL®, formulated at

MITOKINYL® improves skin complexion – Chromaticity and the Asian panel Study in vivo(1) on Asian volunteers.

After 28 days of twice daily applications, MITOKINYL®, formulated at

(1) conducted by the Laboratory of Skin Engineering and Biology of the West China Hospital located in the city of Chengdu, Sichuan province, directed by Professor Li Li..